CNTA
Centessa Pharmaceuticals plc · Healthcare · Biotechnology
Momentum inputs (comparable managers):
holder breadth +7.7% ·
share flow +17.4% ·
net new positions +7.1%
— formula
Broad accumulation — rising shares across more holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2025
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q1 2026 | 55 | +3 | 43.68M | $1.73B | +11 | −8 |
| Q4 2025 | 52 | -1 | 46.49M | $1.16B | — | −1 |
| Q3 2025 | 17 | 0 | 26.76M | $648.81M | +1 | −1 |
| Q2 2025 | 14 | +1 | 24.28M | $319.09M | +2 | −1 |
| Q1 2025 | 11 | 0 | 16.47M | $236.89M | — | — |
| Q4 2024 | 11 | -1 | 15.51M | $259.80M | — | −1 |
| Q3 2024 | 11 | +2 | 13.11M | $209.59M | +2 | — |
| Q2 2024 | 9 | — | 8.99M | $81.17M | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Adage Capital Partners ✦ | 8.40M | +20.8% | $110.42M | 0.2% | ▲ Add | 5 | SEC ↗ |
| 2 | T. Rowe Price ✦ | 5.91M | +10.6% | $77.63M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 3 | Fidelity (FMR) ✦ | 3.83M | — | $50.28M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | Point72 Asset Management ✦ | 2.59M | +13.3% | $34.05M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 5 | Millennium Management ✦ | 1.66M | +172.2% | $21.78M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 6 | Capital World Investors ✦ | 416.82K | New | $5.48M | 0.0% | New | 1 | SEC ↗ |
| 7 | Renaissance Technologies ✦ | 384.90K | +116.2% | $5.06M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 8 | BlackRock ✦ (passive) | 381.12K | — | $5.01M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | BlackRock ✦ (passive) | 381.12K | — | $5.01M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | Marshall Wace ✦ | 343.32K | +152.4% | $4.51M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 11 | Marshall Wace ✦ | 343.32K | +152.4% | $4.51M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 12 | Wellington Management ✦ | 149.45K | +7.7% | $1.96M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 13 | Wellington Management ✦ | 149.45K | +7.7% | $1.96M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 14 | Wellington Management ✦ | 149.45K | +7.7% | $1.96M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 15 | Geode Capital Management ✦ (passive) | 87.44K | +44.7% | $1.15M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 16 | Two Sigma Investments ✦ | 72.14K | +371.5% | $947,972 | 0.0% | ▲ Add | 5 | SEC ↗ |
| 17 | State Street Global Advisors ✦ (passive) | 45.91K | -1.6% | $603,284 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 18 | D. E. Shaw & Co. ✦ | 15.76K | New | $207,139 | 0.0% | New | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| Capital World Investors | $5.48M | 0.0% |
| D. E. Shaw & Co. | $207,139 | 0.0% |
Exited
| Citadel Advisors | $10.16M | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 159 holders, 148.16M shares, $5.86B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.